Zydus Lifesciences’ Ahmedabad plant passes FDA inspection with no observations
AHMEDABAD, INDIA - Indian lifesciences company, Zydus Lifesciences, announced on Tuesday that its injectables manufacturing facility at Zydus Biotech Park in Changodar, Ahmedabad has passed ... Read More
Zydus Lifesciences gets FDA final approval for Balsalazide Disodium Capsules
Zydus Lifesciences, along with its subsidiaries and affiliates, has achieved a significant milestone with the final approval from the US Food and Drug Administration (FDA) ... Read More
Zydus Lifesciences initiates phase 4 trial for Saroglitazar Mg in NAFLD
Zydus Lifesciences, an Indian life sciences company, has announced the commencement of Phase IV Real World Data Registry trial "EVIDENCES-XI" for Saroglitazar Magnesium (Mg) in ... Read More
Zydus Lifesciences gets FDA final approval for Sucralfate Tablets
Zydus Lifesciences has bagged final approval to manufacture and market Sucralfate Tablets USP, 1 gram from the US Food and Drug Administration (FDA). The approved ... Read More
Zydus Lifesciences’ Menostar Transdermal System generic gets FDA final approval
Zydus Lifesciences has secured final approval from the UA Food and Drug Administration (FDA) for Estradiol Transdermal System USP, 0.014 mg/day. The approved product which ... Read More
Zydus Lifesciences wins FDA final approval for Isoproterenol HCL injection
Zydus Lifesciences has secured final approval for Isoproterenol Hydrochloride (HCL) Injection USP, 0.2 mg/mL and 1 mg/5 mL (0.2 mg/mL) single-dose vials from the US ... Read More
Zydus Lifesciences bags FDA final approval for Tavaborole Topical Solution
Zydus Lifesciences has won final approval from the US Food and Drug Administration (FDA) for Tavaborole Topical Solution, 5%. The approved product is a generic ... Read More
Zydus Lifesciences gets FDA final approval for Erythromycin Tablets generic
Zydus Lifesciences said that it has secured final approval for Erythromycin Tablets USP, 250 mg and 500 mg from the US Food and Drug Administration ... Read More
Zydus Lifesciences gets FDA final approval for Olanzapine tablets
Zydus Lifesciences said that it has secured final approval for Olanzapine Orally Disintegrating Tablets USP, 5 mg, 10mg, 15 mg, and 20 mg from the ... Read More
Zydus Lifesciences gets FDA final approval for Vigabatrin for Oral Solution
Zydus Lifesciences has bagged final approval for seizures drug Vigabatrin for Oral Solution USP, 500 mg from the US Food and Drug Administration (FDA). Vigabatrin ... Read More